{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:58:13Z","timestamp":1753891093613,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Community-acquired <jats:italic>Roseomonas mucosa<\/jats:italic> sepsis can lead to significant morbidity and mortality if not diagnosed promptly. We report a case of a 59-year-old woman with community-acquired <jats:italic>Roseomonas mucosa<\/jats:italic> sepsis who presented with persistent fever progressing to septic shock, despite repeatedly negative host-response biomarker results. Initial metagenomic analysis of peripheral blood suggested <jats:italic>Pseudomonas aeruginosa<\/jats:italic> infection. However, a peripheral blood culture identified <jats:italic>Roseomonas mucosa<\/jats:italic> as the causative pathogen. She was cured after switching to meropenem according to blood cultures and antimicrobial susceptibility testing.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1521161","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:12:54Z","timestamp":1744261974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A rare case of community-acquired Roseomonas mucosa sepsis that presented with persistently normal host-response biomarkers"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaomei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.12.3275-3283.1993","article-title":"Roseomonas, is a new genus associated with bacteremia and other human infections","volume":"31","author":"Rihs","year":"1993","journal-title":"J Clin Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1086\/420824","article-title":"Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer","volume":"38","author":"D\u00e9","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2020.1785742","article-title":"Roseomonas species infections in humans: a systematic review","volume":"32","author":"Ioannou","year":"2020","journal-title":"J chemother (Florence Italy)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13104-017-2538-4","article-title":"Characterisation of Roseomonas mucosa isolated from the root canal of an infected tooth","volume":"10","author":"Diesendorf","year":"2017","journal-title":"BMC Res notes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.diagmicrobio.2011.11.013","article-title":"Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates","volume":"72","author":"Wang","year":"2012","journal-title":"Diagn Microbiol Infect disease"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet (London England)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4137\/BMI.S29519","article-title":"Biomarkers for sepsis: what is and what might be","volume":"10","author":"Biron","year":"2015","journal-title":"biomark Insights"},{"key":"B9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biomedicines8110494","article-title":"Current evidence and limitation of biomarkers for detecting sepsis and systemic infection","volume":"8","author":"Hung","year":"2020","journal-title":"Biomedicines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6737","article-title":"Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review","volume":"51","author":"Tsai","year":"2012","journal-title":"Internal Med (Tokyo Japan)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.05.024","article-title":"Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental","volume":"22","author":"Romano-Bertrand","year":"2016","journal-title":"Clin Microbiol infection"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2016.36.4.367","article-title":"Two cases of bacteremia due to roseomonas mucosa","volume":"36","author":"Kim","year":"2016","journal-title":"Ann Lab Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01437-12","article-title":"Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis","volume":"50","author":"Boyd","year":"2012","journal-title":"J Clin Microbiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40560-019-0374-4","article-title":"Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis","volume":"7","author":"Kondo","year":"2019","journal-title":"J Intensive Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06956-y","article-title":"How to use biomarkers of infection or sepsis at the bedside: guide to clinicians","volume":"49","author":"P\u00f3voa","year":"2023","journal-title":"Intensive Care Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect diseases"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.v120.4","article-title":"The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis","volume":"120","author":"Tan","year":"2019","journal-title":"J Cell Biochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13054-021-03862-5","article-title":"Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review","volume":"26","author":"Barichello","year":"2022","journal-title":"Crit Care (London England)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5VMR0118-021RR","article-title":"Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality","volume":"104","author":"Frydrych","year":"2018","journal-title":"J leukocyte Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3390\/cells9081892","article-title":"Repetitive intermittent hyperglycemia drives the M1 polarization and inflammatory responses in THP-1 macrophages through the mechanism involving the TLR4-IRF5 pathway","volume":"9","author":"Al-Rashed","year":"2020","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit Care (London England)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1105-z","article-title":"Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids","volume":"27","author":"Gu","year":"2021","journal-title":"Nat\u00a0Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1338861","article-title":"Comparison of metagenomic next-generation sequencing and blood culture for diagnosis of bloodstream infections","volume":"14","author":"Yu","year":"2024","journal-title":"Front\u00a0Cell infection Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1521161\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:12:55Z","timestamp":1744261975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1521161\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2025.1521161"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1521161","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"article-number":"1521161"}}